L01BB05 • fludarabine • Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues
Fludarabine is a medication used to treat certain types of blood cancer, especially chronic lymphocytic leukemia. This medicine works by inhibiting the growth and multiplication of cancer cells, helping to control the disease and prolong patient survival. Fludarabine is often used when other treatments have not been successful or are not suitable for the patient.
Fludarabine is usually administered by intravenous infusion under the strict supervision of medical staff. The dose and duration of treatment are determined by the doctor based on the patient's general condition, type, and stage of the disease. It is essential to follow the treatment as directed to achieve the best results.
Side effects of fludarabine may include a decrease in blood cell counts, which increases the risk of infections, bleeding, or severe fatigue. Other reactions may include nausea, vomiting, diarrhea, or skin rashes. In rare cases, severe reactions such as nervous system damage or serious allergic reactions may occur.
Fludarabine is a powerful medication, and its administration requires careful monitoring and regular tests. Inform your doctor about any unusual symptoms or other medications you are taking. Following medical recommendations is essential for the safety and effectiveness of the treatment.
Substance: fludarabine
Date of last drug list: 01-07-2017
Commercial code: W56211001
Concentration: 50mg
Pharmaceutical form: lyophilisate for solution for injection / infusion
Quantity: 5
Product type: original
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.